The Japanese drugmaker Chugai announced that it has developed a vaccine for the Middle Eastern Respiratory Syndrome


Key Highlights :

1. China has approved its first domestically developed mRNA vaccine against COVID-19, which could give the country an additional option to tackle future outbreaks.\n\n2. However, the vaccine's sales outlook is moderate given the country's return to normal.\n\n3. mRNA vaccines are a "very solid option" for countries including China, and investors are now awaiting the outcome of the US Federal Reserve's monetary policy meeting.

The Chinese government has approved its first domestically developed mRNA vaccine against COVID-19, which could give the country an additional option to tackle future outbreaks. However, the vaccine's sales outlook is moderate given the country's return to normal.


The Economic Times on WhatsApp. ... more less

Continue Reading at Source : economictimes_indiatimes
Previous Post Next Post